darzalex
(Daratumumab)Janssen Biotech, Inc.
Usage: DARZALEX is indicated for adult patients with multiple myeloma, used in various combinations with other therapies for newly diagnosed patients ineligible for stem cell transplant, relapsed or refractory cases after prior treatments, and as monotherapy for patients with extensive treatment history or double-refractory status.